Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
レビュー
顧客レビュー
Application Protocols
No tested application protocols are provided for this specific item in the Product Data.
General, non-item-specific guidance for small-molecule kinase probe use:
Preparing stocks:
Bring compound to room temperature in a desiccator before opening. Prepare 10–20 mM stocks in dry DMSO, filter-sterilize if needed (0.22 µm PTFE), and aliquot.
Biochemical inhibition assay (outline):
Assemble reaction with recombinant kinase, substrate, ATP, Mg2+, and serial dilutions of compound (0.1 nM–100 µM range as appropriate). Maintain constant DMSO across wells. Incubate per kit instructions and read via luminescence/fluorescence/ADP-Glo.
Cell-based assay (outline):
Plate cells to desired density, pre-incubate if needed, dose compound in a range of concentrations, and harvest at multiple time points. Quantify pathway biomarkers (e.g., phospho-proteins) by Western blot or ELISA. Include vehicle and positive-control inhibitors.
Data quality controls:
Run replicates (biological and technical), apply Hill-slope constrained curve fitting, and verify lack of colloidal aggregation (detergent counterscreen).
For validated, item-specific protocols, please refer to peer-reviewed literature on SGI-1776 and the lot-specific documentation when available.
Biological Roles
Research context (literature/general): SGI-1776 is widely referenced as a small-molecule inhibitor used to probe serine/threonine kinase signaling pathways in cellular systems. Compounds in this class are typically designed to bind to the ATP site, modulating phosphorylation cascades that influence cell cycle progression, survival signaling, and metabolic regulation.
Use in pathway studies (general):
Helps dissect kinase-dependent regulation of transcription factors, apoptotic regulators, and metabolic enzymes by transiently modulating enzymatic activity.
Enables time-resolved perturbation experiments to differentiate primary versus compensatory pathway effects.
Selectivity and off-target considerations:
Many ATP-competitive inhibitors exhibit polypharmacology. For rigorous interpretation, pair chemical perturbation with orthogonal controls (inactive analogs, genetic knockdown/knockout), and perform kinome-wide profiling where possible (literature best practices).
Biochemical handling:
Verify protein-binding and serum-binding effects when moving from cell-free to cellular assays; adjust nominal concentrations accordingly.
Consider efflux transporters and permeability in cell-based assays; use counterscreens (e.g., P-gp overexpressing lines) to evaluate apparent potency shifts.
Item-specific biological target details (e.g., primary kinase(s), KD/IC50 values) are not provided in the Product Data and should be confirmed from primary literature and your in-house assays. For research use only.
Buffer Applications
Not typically applicable. SGI-1776 is not a buffering agent and does not constitute a buffer system.
Practical note (general): When dosing into aqueous buffers for biochemical or cellular assays, prepare a concentrated DMSO stock and dilute into the buffer immediately before use, keeping final DMSO at 0.1–1% v/v as assay-tolerated. Monitor for precipitation and adjust with gentle warming or minimal co-solvent if necessary.
No specific buffer formulations are associated with this item.
Green Alternatives
This section is minimally applicable. SGI-1776 is a discrete research compound rather than a process solvent or commodity reagent where greener substitutions are typically considered.
Considerations (general):
For solution handling, choose greener cosolvents where feasible (e.g., aqueous buffer with minimal DMSO content) while maintaining solubility and assay performance.
When cleaning glassware or preparing mobile phases, prefer lower-toxicity solvents (e.g., ethanol, isopropanol) over more hazardous options where method requirements allow.
Waste minimization:
Use microplate formats, small-volume aliquots, and high-concentration stocks to reduce solvent and compound waste.
Consolidate organic waste streams and follow institutional green-chemistry policies for disposal.
There are no “alternative compounds” to SGI-1776 for substitution within this product listing; selection of a different probe should be based on biological target requirements and data quality considerations.
Pharmaceutical Uses
Intended use per Product Data: For research use only.
Typical roles of such compounds in pharmaceutical R&D (general; no therapeutic claims):
Tool compound for target validation, pathway deconvolution, and mechanism-of-action studies in discovery research.
Reference standard in analytical method development (e.g., LC–MS quantitation in ADME studies) and impurity profiling.
Control article for in vitro DMPK assays (microsomal stability, plasma protein binding, permeability) and early formulation screening (solubility, salt screening, excipient compatibility) performed solely for research.
Regulatory status:
Not a pharmacopeial excipient or API specification in this listing. No clinical or diagnostic use is implied.
Formulation experiments (general guidance):
Evaluate DMSO, PEG400, and aqueous cosolvent systems for short-term in vivo preclinical research only if permitted by institutional protocols; maintain clear segregation from any clinical manufacturing activities.
Any statements on dosage, efficacy, or clinical application are out of scope and not provided. Use strictly in laboratory research settings.
Physical Properties
Item-specific specifications are not provided in the Product Data; consult the CoA/Spec Sheet for authoritative values.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Melting point (literature/general for many kinase inhibitors): often solid with MP in the 100–250 °C range; confirm for SGI-1776 from CoA.
Solubility (general guidance):
DMSO: Many ATP-competitive inhibitors are readily soluble; 10–50 mM stock solutions are commonly prepared (literature/general). Verify actual solubility limits for SGI-1776 before use.
Aqueous buffers: Often limited aqueous solubility unless aided by cosolvent or pH adjustment (literature/general). Test empirically.
Alcohols (MeOH/EtOH) and DMF: frequently moderate to good solubility for similar scaffolds (literature/general).
LogP/logD, pKa, refractive index, density: Not specified for this item; refer to CoA/Spec Sheet.
Stability (general handling observations): Many heteroaromatic kinase probes are stable as dry solids at low temperature and protected from light/moisture; avoid prolonged exposure to ambient humidity. For SGI-1776, follow the storage guidance provided (-20 °C) and consult SDS/CoA for stability data.
All numeric property values for this specific item must be confirmed from the CoA/Spec Sheet.
Quality and Grades
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
What to expect from research-grade small molecules:
Tight control of identity (e.g., 1H NMR, 13C NMR, LC–MS) and purity by HPLC/UPLC area%.
Trace residual solvents and water levels may be reported (e.g., by GC and Karl Fischer) on the CoA; verify for this lot.
Analytical package (general best practices for kinase inhibitors):
Chromatographic purity typically ≥95% for screening use, with single dominant LC peak and defined retention time (literature/general expectation; confirm on CoA).
Structural confirmation may include HRMS and NMR; some suppliers provide additional data (IR, elemental analysis) where relevant.
Stabilizers/additives: Not specified for this item; refer to CoA/Spec Sheet. Most solid bioactives are provided neat without preservatives unless otherwise noted.
Implications for use:
For biochemical assays, low non-volatile impurities and defined polymorph/solvate state improve reproducibility.
If LC–MS background matters (e.g., in metabolomics), request low-UV/low-fluorescence impurities data.
For authoritative specifications (purity threshold, residual solvent limits, water content, counterion/solvate state), consult the lot-specific CoA/Spec Sheet.
Reaction and Applications
Primary use case (for this catalog item): small-molecule tool compound for research use, commonly employed in biochemical and cell-based assays to interrogate kinase-dependent signaling pathways (literature/general). No medical or clinical use is intended or implied.
Assay applications (general for kinase probes):
Enzyme inhibition assays (biochemical IC50 determination) with ATP-competitive mode-of-action readouts.
Cell-based pathway modulation studies with endpoint or kinetic phospho-protein measurements (e.g., Western blot, ELISA, phospho-flow), ensuring appropriate counterscreens for off-target effects.
Target engagement methods such as CETSA or NanoBRET target-binding (literature techniques) can be adapted; confirm compatibility with SGI-1776 experimentally.
Practical tips:
Prepare fresh DMSO stocks and store aliquots at -20 °C to minimize freeze–thaw.
Confirm compound integrity by LC–MS/UPLC before critical experiments.
Include DMSO vehicle controls and concentration–response curves spanning at least 8–10 points (half-log spacing) for robust curve fitting.
Assess compound aggregation risk (use low detergent levels, e.g., 0.01–0.05% Tween-20, and counterscreen with detergent present) as a general best practice for hydrophobic inhibitors.
Not a synthetic reagent: SGI-1776 is not typically used as a building block or catalyst; synthetic transformations are generally not applicable. See “Biological Roles” and “Application Protocols” for more relevant guidance.
Item-specific activity/selectivity data are not provided here; consult primary literature and perform in-house validation.
Reaction Conditions
Not directly applicable. SGI-1776 is supplied as a research compound for use in biochemical and cell-based assays rather than as a reagent for chemical transformations.
Assay handling conditions (general guidance):
Stock solutions: commonly 10–20 mM in anhydrous DMSO; store aliquots at -20 °C.
Biochemical assays: room temperature operations are typical; include Mg2+/Mn2+ and ATP concentrations consistent with your kinase assay kit. Adjust DMSO to match controls.
Cell assays: dose-response across multiple time points (e.g., 1–24 h) to capture kinetics. Monitor cytotoxicity as a general control for off-target effects.
Stability considerations (general):
Minimize light and moisture exposure. Avoid repeated freeze–thaw; use single-use aliquots.
Verify integrity by LC–MS before key experiments.
No item-specific reaction temperatures, catalysts, or yields are applicable or provided for this product.
Safety and Handling
GHS classification, signal word, pictograms, and H-statements: Not specified for this item; consult the product SDS for authoritative hazard information.
General laboratory precautions (good practice):
Handle in a chemical fume hood; avoid inhalation of dust or aerosols.
Wear appropriate PPE: lab coat, safety glasses, and suitable chemical-resistant gloves (e.g., nitrile). Consider double-gloving when handling DMSO stocks due to transdermal transport potential.
Avoid contact with skin and eyes; wash thoroughly after handling.
Incompatibilities (general):
Strong oxidizers and strong acids/bases may degrade heteroaromatic small molecules; segregate accordingly.
For DMSO or DMF solutions, avoid contact with oxidizing agents and halogenating reagents.
First aid (overview; defer to SDS):
Inhalation: move to fresh air; seek medical attention if symptoms occur.
Skin/eye contact: rinse with water for at least 15 minutes; remove contaminated clothing; seek medical advice if irritation persists.
Ingestion: rinse mouth; do not induce vomiting; obtain medical attention.
Spill and disposal:
Small spills: absorb with inert material, collect in chemical waste.
Disposal: treat as hazardous organic laboratory waste in accordance with institutional and regulatory requirements.
Special risks:
Many bioactive research chemicals can have potent biological activity at low doses. Minimize exposure and avoid aerosolization. Use secondary containment for solutions.
Always consult the SDS for SGI-1776 for definitive hazard and response information.
Solvent Selection
Given SGI-1776 is a hydrophobic, heteroatom-containing small molecule (literature context), solvent choice typically aims to balance solubility, chemical stability, and assay compatibility.
Polarity class (general): Moderately to strongly polar aprotic solvents (DMSO, DMF, NMP) often dissolve kinase inhibitors well. Alcohols (MeOH/EtOH) can be secondary choices; aqueous solubility is often limited without cosolvent.
Typical miscibility profile (general):
DMSO: miscible with water and common organics; favored for preparing concentrated stocks for biological assays.
DMF/NMP: high solvency power; consider toxicity and downstream compatibility.
MeOH/EtOH/IPA: useful for intermediate solubility and for co-solvent systems.
Practical use scenarios:
Screening stocks: prepare 10–20 mM solutions in anhydrous DMSO (general practice). Validate actual solubility for SGI-1776 empirically before scaling.
Aqueous dosing: dilute DMSO stock into buffer to a final DMSO of 0.1–1% v/v, monitoring for precipitation.
Solid-phase handling: minimize moisture; weigh quickly and cap promptly.
Comparison (general considerations):
DMSO vs DMF: DMSO preferred for biological compatibility; DMF offers similar solvency but is less favored in live-cell contexts.
MeCN: may have limited solubility for polyfunctional heteroaromatics; test as needed.
Item-specific solubility and solvent compatibility are not specified for this product; consult the CoA/Spec Sheet and perform a small-scale solubility screen under your exact conditions.
Storage and Reconstitution
Storage conditions (item-specific, per Product Data):
Store at -20 °C.
Shipped in an ice chest with ice pads to maintain a cold chain.
Handling:
Allow the container to equilibrate to room temperature in a desiccator before opening to avoid moisture condensation.
Reseal promptly; purge with inert gas if feasible and return to -20 °C.
Stability: Not specified for this item; refer to CoA/Spec Sheet. As general practice, protect from light and moisture.
Reconstitution (general guidance for kinase inhibitors; verify experimentally for SGI-1776):
Prepare concentrated stock solutions in anhydrous DMSO (e.g., 10–20 mM). Vortex and, if necessary, gently warm (≤40 °C) to aid dissolution. Do not overheat.
Filter sterilize through 0.22 µm PTFE if sterility is required.
Aliquot into single-use vials to avoid repeated freeze–thaw cycles; store aliquots at -20 °C.
Working solutions:
Dilute DMSO stocks into assay buffer/culture medium immediately before use, keeping final DMSO ≤1% v/v unless your system tolerates more. Inspect for precipitation.
Always consult the lot-specific CoA/Spec Sheet and SDS for definitive guidance on stability, solubility, and safe handling for this item.
Structure and Identity
Item-specific identifiers (per Product Data):
SKU: S1416638
Product Name: SGI-1776
CAS: 1173928-26-1
PubChem CID: 56843465
InChIKey: Not specified for this item; refer to CoA/Spec Sheet. (Product Data lists a non-standard token: "388417")
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Composition:
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Structural notes (general/literature):
SGI-1776 is described in the literature as a small-molecule kinase inhibitor scaffold. Published reports characterize it as a heteroaromatic, polyfunctional small molecule with multiple hydrogen-bond donors/acceptors typical of ATP-competitive kinase probes. Confirm exact structure from primary literature or the CoA.
2D/functional group description (general):
Typical kinase-inhibitor motifs include heteroaromatic rings (e.g., pyrazole/indazole/imidazolidinone-type features have been reported in related series), secondary/tertiary amines or urea/amide linkages for hinge binding, and polar substituents for solubility. The precise arrangement for SGI-1776 should be verified against the certificate of analysis.
Note: To avoid contradictions, all definitive structural parameters for this catalog item should be taken from the CoA/Spec Sheet.
Synthetic Utility
This product is a finished small-molecule probe and is not typically employed as a reagent, catalyst, or building block in synthetic organic chemistry.
Retrosynthetic value: Limited. The scaffold contains multiple heteroaromatic elements (literature context for kinase inhibitors) that are themselves products of multi-step synthesis; disassembly into simpler synthons is non-trivial and not generally practiced for routine synthesis.
If pursuing analog synthesis (medicinal chemistry context; general):
Common transformations for related scaffolds include heteroaryl coupling (e.g., Suzuki–Miyaura, Buchwald–Hartwig), urea/amide couplings, and N-alkylations on heterocycles.
Protecting-group strategies may be required to differentiate multiple nucleophilic sites; late-stage diversification via cross-coupling or C–H activation can be considered.
Analytical characterization for analogs (general best practice):
Purity by UPLC (UV and MS), full NMR assignment, HRMS confirmation, and, when relevant, chiral purity assessment.
For this catalog item, no reagent-like synthetic applications are specified. Refer instead to “Reaction & Applications” and “Application Protocols” for its role as a research probe.
Target Specificity
Item-specific target information is not provided in the Product Data.
General note (literature/best practices):
When deploying a small-molecule probe in biological systems, establish its target profile using orthogonal methods: biochemical IC50/Ki determination, kinome-wide binding/inhibition panels, thermal shift assays (CETSA/DSF), and cellular target engagement (e.g., NanoBRET).
Validate phenotypes with multiple probes where possible and include inactive/less-active analog controls to mitigate chemotype-specific artifacts.
For definitive specificity/affinity data for SGI-1776, consult primary literature and perform in-house profiling under your assay conditions.
よくある質問
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1173928-26-1. InChIKey VUAYTLGZIBSISZ-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.